New and Generic Drug Approvals:

*ABRAXANE (paclitaxel) I.V. Suspension, Abraxis Bioscience, Inc., Labeling Revision *ALOCRIL (nedocromil sodium) Ophthalmic Solution, Allergan, Inc., Labeling Revision *FLOVENT HFA (fluticasone propionate) Inhalation Aerosol, GlaxoSmithKline, Labeling Revision *FORTERO(teriparatide [rDNA origin]) Subcutaneous Injection, Eli Lilly and Co., Control Supplement *OPTIVAR (azelastine hydrochloride) Ophthalmic Solution, Meda Pharmaceuticals, Inc., Package Change *REQUIP XL (ropinirole) Extended-Release Tablets, GlaxoSmithKline, Approval *SUPPRELIN LA (histrelin acetate) Subcutaneous Implant, Indevus Pharmaceuticals, Inc., Package Change *TYKERB (lapatinib ditosylate) Tablets, GlaxoSmithKline, Labeling Revision 


Zynchros Pharmacy Services